Table 3 Required increase in health expenditure by different sources to provide HCV treatment
Country | Total price of Generic | Increase in THE as % of GDP | Increase in THE | Increase in GovtE | Increase in PrvtE | Increase in OOPE | Increase in ODA | Increase in THE plus ODA |
|---|---|---|---|---|---|---|---|---|
Egypt | $5681.3 | 5.6%–7.3% | 31% | 80% | 50% | 55% | 2390% | 30% |
Ethiopia | $507.0 | 4.9%–5.7% | 17% | 29% | 41% | 52% | 40% | 12% |
Nigeria | $6086.3 | 3.7%–5.0% | 34% | 136% | 46% | 48% | 510% | 32% |
DRC | $82.5 | 4.3%–4.5% | 5% | 15% | 9% | 14% | 14% | 4% |
Cameroon | $1104.8 | 4.1%–7.9% | 92% | 403% | 120% | 139% | 831% | 83% |
Rwanda | $356.3 | 7.5%–11.9% | 59% | 154% | 95% | 210% | 127% | 40% |
South Africa | $474.8 | 8.8%–9.0% | 2% | 4% | 3% | 27% | 98% | 2% |